Venus Concept Inc (VERO)

Venus Concept's stock price has significantly declined over the past year. Key events include Q2 and Q3 2025 financial results, the sale of the Venus Hair business to Meta Health Group, debt-to-equity exchange transactions, FDA clearance for Venus Nova, and a stock surge in December 2025. In Q2 2025, Venus Concept reported a year-over-year decline in total revenue but a quarter-over-quarter increase. Gross profit decreased, and the GAAP net loss was significant. The sale of the Venus Hair business aimed to focus on the global medical aesthetics business. Debt-to-equity exchange transactions reduced outstanding debt. Q3 2025 saw a decrease in total revenue due to softness in the Hair Restoration business, with a significant GAAP net loss. Energy-Based Device sales showed signs of stabilization. The FDA clearance for Venus Nova is expected to contribute to sequential growth in Q4. The stock experienced a surge on December 16, 2025.

Information regarding specific seasonal demand patterns for Venus Concept, Inc.'s products and services is not explicitly detailed. While "VERO Seasonality" is mentioned, the actual patterns themselves are not presented.

Venus Concept, Inc. (VERO) is a global medical technology company that specializes in minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company operates in the Health Care sector, focusing on Medical/Dental Instruments. Its product portfolio includes aesthetic device platforms like Venus Legacy and hair restoration systems like NeoGraft and ARTAS iX.

Venus Concept has a global presence, reaching over 60 countries and operating in 10 direct markets. The company often uses a subscription-based business model in North America and its established direct global markets.

Venus Concept's brand reputation is indirectly reflected in its financial performance and strategic initiatives. The FDA clearance of Venus Nova could enhance its reputation for innovation. However, the decline in total revenue and financial losses could negatively impact market perception. The company's efforts to improve its financial condition indicate a focus on regaining market confidence.

Venus Concept Inc. has a mixed ownership structure. Institutional investors own approximately 7.03% to 7.72% of the stock, while individual insiders hold about 0.66% to 0.821%. The general public and individual investors hold a significant portion, around 79.7% to 92.31% of the shares. Major institutional owners include Essex Woodlands Management, DRW Securities, UBS Group AG, and others.